Inge Haas
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 8
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 2
-
- Head and Neck Cancer Studies 3
- Co-authors
- Uwe Ganzer (9 shared papers)Thomas Karl Hoffmann (3 shared papers)H. Bier (5 shared papers)Ulrich Hauser (2 shared papers)Rainer Engers (1 shared paper)Anke Van Lierop (1 shared paper)D. Häfner (1 shared paper)Paul Stasiecki (1 shared paper)
- Journals
- European Archives of Oto-Rhino-Laryngology (6 papers)Cancer Immunology Immunotherapy (2 papers)Journal of Chromatography A (1 paper)ORL (1 paper)Laryngo-Rhino-Otologie (2 papers)
- Partner nations
- GermanyDenmarkNetherlands
In The Last Decade
Inge Haas
16 papers receiving 555 citations
Peers
Comparison fields: 5 of 52
- Otorhinolaryngology 219
- Oncology 280
- Immunology 125
- Oral Surgery 25
- Radiology, Nuclear Medicine and Imaging 63
Countries citing papers authored by Inge Haas
This map shows the geographic impact of Inge Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Haas more than expected).
Fields of papers citing papers by Inge Haas
This network shows the impact of papers produced by Inge Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Haas. The network helps show where Inge Haas may publish in the future.
Co-authors
The 16 scholars most cited alongside Inge Haas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 138 | |
| 2 | 2007 | 123 | |
| 3 | 2001 | 84 | |
| 4 | 1998 | 82 | |
| 5 | Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines. | 1998 | 61 |
| 6 | 2002 | 36 | |
| 7 | 1995 | 26 | |
| 8 | 2003 | 7 | |
| 9 | 1987 | 5 | |
| 10 | 1995 | 4 | |
| 11 | 2002 | 3 | |
| 12 | 2000 | 3 | |
| 13 | 1998 | 2 | |
| 14 | 1996 | 1 | |
| 15 | 1999 | 1 | |
| 16 | 1996 | 1 | |
| 17 | 2010 | 0 | |
| 18 | 2010 | 0 |
About Inge Haas
Inge Haas is a scholar working on Oncology, Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging, Cell Biology and Molecular Biology, having authored 18 papers that have together received 577 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Head and Neck Cancer Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers), RNA Interference and Gene Delivery (2 papers), Lung Cancer Treatments and Mutations (2 papers), Syphilis Diagnosis and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Otorhinolaryngology (219 citations), Oncology (280 citations), Immunology (125 citations), Oral Surgery (25 citations) and Radiology, Nuclear Medicine and Imaging (63 citations). Inge Haas has collaborated with scholars based in Germany, Denmark and Netherlands. Frequent co-authors include Uwe Ganzer, Thomas Karl Hoffmann, H. Bier, Ulrich Hauser, Rainer Engers, Anke Van Lierop, D. Häfner, Paul Stasiecki, K. -A. Reiffen and P. Koldovský. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, Cancer Immunology Immunotherapy, Journal of Chromatography A, ORL and Laryngo-Rhino-Otologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.